EyePoint Pharmaceuticals (EYPT) reported Q3 EPS of ($0.49), $0.14 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $10.01 million versus the consensus estimate of $11.61 million.
EyePoint Pharmaceuticals (EYPT) reported Q3 EPS of ($0.49), $0.14 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $10.01 million versus the consensus estimate of $11.61 million.